Femasys (FEMY) Convertible Debt (2023 - 2025)
Femasys (FEMY) reported Convertible Debt of $3.2 million for Q4 2025, down 37.28% quarter-over-quarter from $5.1 million in Q3 2024.
Femasys (FEMY) Convertible Debt (2023 - 2025) Analysis & Trends
Femasys has reported Convertible Debt for 3 years, with the latest figure at $3.2 million in Q4 2025.
- For the quarter ending Q4 2025, Convertible Debt changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (changed N/A YoY), and the FY2025 full-year result was $3.2 million, changed N/A from the prior year.
- Convertible Debt for Q4 2025 stood at $3.2 million, down from $5.1 million in the prior quarter.
- The five-year high for Convertible Debt was $5.1 million in Q3 2024, with the low at $3.2 million in Q4 2025.
- Historically, Convertible Debt has averaged $4.3 million across 3 years, with a median of $4.5 million in 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2024 | 5.07 Mn |
| Jun 30, 2024 | 4.76 Mn |
| Mar 31, 2024 | 4.47 Mn |
| Dec 31, 2023 | 4.26 Mn |